PharmExec Direct | From the editors of Pharmaceutical Executive Visit the PharmExec website
Send Us Some Feedback
 

December 17, 2009 | ISSUE NUMBER 129 VOL 7

Recall
Sanofi Gets a Bad Batch of H1N1 Vaccines
Sanofi-Aventis is recalling hundreds of thousands of doses of the childrens’ version of its H1N1 vaccine. Conspiracy theorists are going to have a field day.

R&D
Gilead and Elan Struggle with Clinical Trials
It’s been a tough week for clinical trials: One drug got canned and another was re-tuned in the wake of failed end points and patient deaths.

Corporate Responsibility
GSK Makes Physician Payments Public
Transparency can be a double-edged sword—especially if you are a doctor receiving money to speak on behalf of a drug company. Sure the pay day is nice, but does the public outing open you up to scrutiny?

People
Dendreon Picks Bishop as COO
One of Pharm Exec’s emerging leaders gets a job bump, from Bayer to Dendreon. Here’s a bite-sized look at the man who jumpstarted the company’s hemophilia franchise.

Profile
One to Watch: Q&A with Paul Dyer
Paul Dyer, eMedia Director, WeissComm Group (WCG), is already on his way to the top not only on PR News’ 15 to watch list, but he’s also a leader in the online healthcare community.

Gwathmey made Rosalie Dunn CEO // Oxford BioTherapeutics appointed Michael Moore, M.D., as non-executive chairman // BioCryst Pharmaceuticals elected Charles A. Sanders, M.D., to its board of directors // Procter & Gamble appointed Angela F. Braly to its board of directors // The North American Neuromodulation Society made Robert Foreman president // Dendreon made Hans Bishop chief operating officer // Northwest Biotherapeutics elected Robert A. Farmer to its board of directors // Omeros elected Daniel K. Spiegelman to its company’s board // Oncolytics Biotech appointed Alan Warrander, M.D, to senior vice president, global licensing and business development // Lotus Pharmaceuticals appointed Jinzhong Han to general manager of the OTC division // MED3OOO appointed Hillary Harlan to chief compliance and ethics officer // Sanofi-aventis appointed Atul Dhir, M.D., as CEO of BiPar Sciences // PRA International appointed Colin Shannon as president, CEO, and director // AlphaRx named Ruby Hui president of China operations // Nektar Therapeutics appointed Dennis Winger to its board of directors //


Advertisement:
9th Annual Forum on Patient Adherence, Compliance and Persistency April 26 - 27, 2010 * Philadelphia, PA
Improve Product Utilization through Patient-Centered Initiatives

The program features varying perspectives from Pharma, Provider, Pharmacy and Government on strategies for effective compliance partnerships. Don’t Miss the 5th Annual Strategic Patient Adherence (SPA) Awards - presented on-site at the conference! For Pharmaceutical Executive's coverage of the 2009 Awards, please click here. For more information on the 5th SPA Awards, email awards@cbinet.com.


For more information: visit www.cbinet.com/PatientCompliance/pcc or call 800-817-8601


Jan 21–22, 2010 Bio/Pharmaceutical Forum on Optimizing the Use of Complex Data Assets, Philadelphia, PA

Jan 25–26, 2010 Pharmaceutical Forum on Strategic Sourcing and Procurement, Philadelphia, PA

Feb 8–9, 2010 3rd Annual Clinical Trial Forecasting and Budgeting, Philadelphia, PA

April 12–14, 2010 19th Annual Partnerships in Clinical Trials, Orlando FL


 
  FindPharma  
  Search  

Survey
Should FDA recognize social media as a new form of communication with its own rules and regulations?
Click To Vote
Quick Links

MILs: An Emerging Tool in Drug Delivery and Theranostics

GSK Wants to Get under Your Skin

Artes and Rhein Minapharm Produce New Therapeutic Protein Target

ICON Central Laboratories Expands its European Facility


Follow Pharm Exec on Twitter

Click Here

User Management
| Subscribe | Update My Profile | Send Feedback | Advertise With Us | Visit PharmExec.com |

You are subscribed to Pharm Exec Direct.. To unsubscribe, click here

To ensure delivery to your Inbox, please add us to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.

Visit Pharmaceutical Executive